The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

@article{DSouza2004ThePE,
  title={The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis},
  author={Deepak Cyril D’Souza and Edward B. Perry and Lisa Macdougall and Yola Ammerman and Thomas Cooper and Yu-Te Wu and Gabriel Braley and Ralitza Gueorguieva and John H. Krystal},
  journal={Neuropsychopharmacology},
  year={2004},
  volume={29},
  pages={1558-1572}
}
Recent advances in the understanding of brain cannabinoid receptor function have renewed interest in the association between cannabinoid compounds and psychosis. In a 3-day, double-blind, randomized, and counterbalanced study, the behavioral, cognitive, and endocrine effects of 0, 2.5, and 5 mg intravenous delta-9-tetrahydrocannabinol (Δ-9-THC) were characterized in 22 healthy individuals, who had been exposed to cannabis but had never been diagnosed with a cannabis abuse disorder. Prospective… 
elta-9-Tetrahydrocannabinol Effects in chizophrenia : Implications for Cognition , sychosis , and Addiction eepak
TLDR
Delta-9-tetrahydrocannabinol is associated with transient exacerbation in core psychotic and cognitive deficits in chizophrenia, and -9-THC might differentially affect schizophrenia patients relative to control subjects.
The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
TLDR
It is confirmed that THC can induce a transient, acute psychotic reaction in psychiatrically well individuals and the extent of the psychotic reaction was not related to the degree of anxiety or cognitive impairment.
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
TLDR
Results indicated that THC increased overall scores on the PSI, negative symptoms on BPRS, and robustly impaired episodic and working memory, and co-administration of CBD did not attenuate these effects.
Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans
TLDR
These results have implications for future research, also in light of cannabis being the most widely used illicit drug.
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?
TLDR
This placebo-controlled, cross-over study aimed to further explore the effect of a single oral dose of olanzapine (with dopaminergic, serotonergic, adrenergic, muscarinergic and histaminergic properties) or two oral doses of diphenhydramine (histamine antagonist) on the effects of intrapulmonarily administered THC.
Psychosis-relevant effects of intravenous delta-9-tetrahydrocannabinol - A mega analysis of individual participant-data from human laboratory studies.
TLDR
Intravenous administration of THC consistently induces psychotomimetic effects that include symptoms across PANSS domains, and healthy subjects who frequently use cannabis, have a blunted psychotomIMetic response.
Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?
TLDR
It is demonstrated that CBD attenuates THC induced subjective and objective effects relevant to psychosis- but in a dose/ratio dependent manner.
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
TLDR
It is suggested that an increase in striatal glutamate levels may underlie acute cannabis-induced psychosis while lower baseline levels may be a marker of greater sensitivity to its acute psychotomimetic effects and may have important public health implications.
...
...

References

SHOWING 1-10 OF 199 REFERENCES
Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users
TLDR
It is demonstrated that oral Δ9-THC impairs episodic memory and learning in a dose-dependent manner whilst sparing perceptual priming and working memory.
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
TLDR
These data indicate that N-methyl-D-aspartate antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.
Endocannabinoids in cognition and dependence.
TLDR
Converging evidence in which performance in a variety of memory tasks is enhanced following either SR141716A treatment or in CB(1) receptor knockout mice indicates that this system may play an important role in modulating cognition.
Cannabinoid/anandamide system and schizophrenia: is there evidence for association?
TLDR
The hypothesis that, during psychotic and related prepsychotic states, the human CNS is unable to correct implausible perceptual hypotheses is tested, which provides evidence of strong similarities between data acquired from patients, suffering from productive schizophrenic psychoses and delta9-THC-intoxicated healthy volunteers.
The psychoactive ingredient of marijuana induces behavioural sensitization
TLDR
Challenge with Δ9‐tetrahydrocannabinol in pre‐exposed animals elicited a complex behavioural syndrome mainly characterized by oral stereotyped items, suggesting that cannabinoids could trigger neurobiological alteration not dissimilar from those observed with more harmful abused drugs.
Comparative Effects of Alcohol and Marijuana on Mood, Memory, and Performance
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.
TLDR
The results indicate that stimulation of cannabinoid CB1 receptors produces an activation of meso-prefrontal dopaminergic transmission in the prefrontal cortex, and the present results suggest that the negative effects of cannabinoids on cognitive processes might be related to the activation of dopamine transmission inThe prefrontal cortex.
...
...